72 related articles for article (PubMed ID: 17668859)
1. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
Luft T; Dreger P; Radujkovic A
Bone Marrow Transplant; 2021 Oct; 56(10):2326-2335. PubMed ID: 34253879
[TBL] [Abstract][Full Text] [Related]
2. Association between conditioning intensity and height growth after allogeneic hematopoietic stem cell transplantation in children.
Uemura S; Hasegawa D; Kishimoto K; Fujikawa T; Nakamura S; Kozaki A; Saito A; Ishida T; Mori T; Ozaki K; Kosaka Y
Cancer Med; 2023 Aug; 12(16):17018-17027. PubMed ID: 37434385
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.
Chaudhury S; Sparapani R; Hu ZH; Nishihori T; Abdel-Azim H; Malone A; Olsson R; Hamadani M; Daly A; Bacher U; Wirk BM; Kamble RT; Gale RP; Wood WA; Hale G; Wiernik PH; Hashmi SK; Marks D; Ustun C; Munker R; Savani BN; Alyea E; Popat U; Sobecks R; Kalaycio M; Maziarz R; Hijiya N; Saber W
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1056-1064. PubMed ID: 26964698
[TBL] [Abstract][Full Text] [Related]
4. Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies.
Hirabayashi K; Nakazawa Y; Sakashita K; Kurata T; Saito S; Yoshikawa K; Tanaka M; Yanagisawa R; Koike K
Sci Rep; 2014 Nov; 4():6942. PubMed ID: 25373730
[TBL] [Abstract][Full Text] [Related]
5. Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease.
Bhatia M; Jin Z; Baker C; Geyer MB; Radhakrishnan K; Morris E; Satwani P; George D; Garvin J; Del Toro G; Zuckerman W; Lee MT; Licursi M; Hawks R; Smilow E; Baxter-Lowe LA; Schwartz J; Cairo MS
Bone Marrow Transplant; 2014 Jul; 49(7):913-20. PubMed ID: 24797180
[TBL] [Abstract][Full Text] [Related]
6. A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation.
Qualter E; Satwani P; Ricci A; Jin Z; Geyer MB; Alobeid B; Radhakrishnan K; Bye M; Middlesworth W; Della-Letta P; Behr G; Muniz M; van de Ven C; Harrison L; Morris E; Cairo MS
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1229-37. PubMed ID: 24769329
[TBL] [Abstract][Full Text] [Related]
7. Late effects and quality of life of childhood cancer survivors: part 1. Impact of stem cell transplantation.
Ishida Y; Honda M; Ozono S; Okamura J; Asami K; Maeda N; Sakamoto N; Inada H; Iwai T; Kamibeppu K; Kakee N; Horibe K
Int J Hematol; 2010 Jun; 91(5):865-76. PubMed ID: 20467848
[TBL] [Abstract][Full Text] [Related]
8. Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases.
Satwani P; Morris E; Bradley MB; Bhatia M; van de Ven C; Cairo MS
Pediatr Blood Cancer; 2008 Jan; 50(1):1-8. PubMed ID: 17668859
[TBL] [Abstract][Full Text] [Related]
9. Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges.
Satwani P; Harrison L; Morris E; Del Toro G; Cairo MS
Biol Blood Marrow Transplant; 2005 Jun; 11(6):403-22. PubMed ID: 15931629
[TBL] [Abstract][Full Text] [Related]
10. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
Resnick IB; Shapira MY; Slavin S
Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
[TBL] [Abstract][Full Text] [Related]
11. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P;
Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375
[TBL] [Abstract][Full Text] [Related]
13. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
